{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:33:48Z","timestamp":1790393628083,"version":"4.1.0"},"reference-count":74,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2020,6,2]]},"DOI":"10.1080\/14740338.2020.1764531","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T09:51:35Z","timestamp":1588326695000},"page":"683-694","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["Nothing is perfect: the safety issues of integrase inhibitor regimens"],"prefix":"10.1080","volume":"19","author":[{"given":"Sof\u00eda","family":"Sc\u00e9vola","sequence":"first","affiliation":[{"name":"HIV and STI Unit, Infectious Disease Service, Hospital Universitari de Bellvitge-IDIBELL, Universitat de Barcelona, L\u2019Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Tiraboschi","sequence":"additional","affiliation":[{"name":"HIV and STI Unit, Infectious Disease Service, Hospital Universitari de Bellvitge-IDIBELL, Universitat de Barcelona, L\u2019Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Podzamczer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105243"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081355"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"cit0004","unstructured":"Gesida: Plan nacional sobre el sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana; 2019 [cited 2019 Dec 20]. Available from: http:\/\/gesida-seimc.org\/category\/guias-clinicas\/"},{"key":"cit0005","unstructured":"AIDSinfo: Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV; 2019 [cited 2019 Dec 20]. Available from: https:\/\/aidsinfo.nih.gov\/guidelines"},{"key":"cit0006","unstructured":"EACS: European Guidelines for the treatment of HIV-positive adults in Europe; 2019 [cited 2019 Dec 20]. Available from: https:\/\/www.eacsociety.org\/guidelines\/eacs-guidelines\/eacs-guidelines.html"},{"key":"cit0007","unstructured":"Update of recommendations on first- and second-line antiretroviral regimens. Geneva, Switzerland: World Health Organization; 2019 (WHO\/CDS\/HIV\/19.15). Licence: CC BY-NC-SA 3.0 IGO. Available from: https:\/\/www.who.int\/hiv\/pub\/arv\/arv-update-2019-policy\/en\/"},{"key":"cit0008","unstructured":"Gu\u00eda de resistencias a los antirretrovirales. Red de investigaci\u00f3n en Sida. Actualizaci\u00f3n; 2019 [cited 2019 Dec 20]. Available from: https:\/\/www.redris.es\/blog\/-\/blogs\/guia-de-resistencias-a-los-antirretrovirales"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu051"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01209-10"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06591-11"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70093-8"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32299-7"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32340-1"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3166"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0424-1"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001781"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12710"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001590"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283612419"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70257-3"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61221-0"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60084-2"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1177\/0956462418812642"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60917-9"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60918-0"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70249-3"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx053"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001279"},{"key":"cit0030","first-page":"4","volume":"21","author":"Hoffmann C","year":"2019","journal-title":"AIDS"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000790"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12468"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky497"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1177\/2042098618798350"},{"key":"cit0035","volume-title":"17th European AIDS Conference","author":"Orkin C","year":"2019"},{"key":"cit0036","volume-title":"17th European AIDS Conference","author":"Hoffmann C","year":"2019"},{"key":"cit0037","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s40271-018-0322-8","volume":"11","author":"Wohl D","year":"2018","journal-title":"Patient"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1807653"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002031"},{"key":"cit0040","unstructured":"[cited 2019 Dec 20]. Available from: https:\/\/www.who.int\/hiv\/mediacentre\/news\/dtg-statement\/en\/"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1905230"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1908155"},{"key":"cit0043","volume-title":"17th European AIDS Conference","author":"Mofenson LM","year":"2019"},{"key":"cit0044","unstructured":"Pereira G, Kim A, Jalil E, et al. No ocurrence of NTD among 382 women on dolutegravir at pregnancy conception in Brazil. IAS; 2019 . [cited 2019 Dec 20]. Available from: http:\/\/programme.ias2019.org\/Abrstract\/4991."},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13548"},{"key":"cit0046","unstructured":"AIDSinfo: Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States; 2019 [cited 2019 Dec 26]. Available from: https:\/\/aidsinfo.nih.gov\/guidelines"},{"key":"cit0047","volume-title":"17th European AIDS Conference","author":"Orkin C","year":"2019"},{"key":"cit0048","volume-title":"17th European AIDS Conference; 2019 Nov 6\u20139, Basel, Switzerland. abstract PS3\/4","author":"Gorwood J"},{"key":"cit0049","unstructured":"European Medicines Agency. EMA\/CHMP\/772068\/2013 Committee for Medicinal Products for Human Use (CHMP) Assessment report. Tivicay. International non-proprietary name: dolutegravir Procedure No. EMEA\/H\/C\/002753\/0000. 2013 November 21. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/tivicay"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904340"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902824"},{"key":"cit0052","volume-title":"17th European AIDS Conference, abstract PS3\/3","author":"McCann K","year":"2019"},{"key":"cit0053","unstructured":"Hare CB, Coll J, Ruane P, et al. The phase 3 DISCOVER study: daily F\/TAF or F\/TDF for HIV preexposure prophylaxis. Conference on Retroviruses and Opportunistic Infections; 2019 March 4\u20137; Seattle, Washington. Abstract 104LB."},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz415.2492"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz999"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002690"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1080\/15284336.2018.1511346"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1080\/25787489.2019.1661696"},{"key":"cit0059","volume-title":"CROI","author":"Swindells S","year":"2019"},{"key":"cit0060","volume-title":"CROI","author":"Orkin C","year":"2019"},{"key":"cit0061","author":"Margolis D","journal-title":"ID-Week."},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz439"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1177\/0956462413481528"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-201545"},{"key":"cit0065","doi-asserted-by":"crossref","unstructured":"Ripamonti D, Benatti SV, Di Filippo E, et al. Drug reaction with eosinophilia and systemic symptoms associated with raltegravir use: case report and review of the literature. AIDS. 2014;28:1077\u20131079.","DOI":"10.1097\/QAD.0000000000000204"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.4103\/ijstd.IJSTD_70_17"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1177\/0956462418764973"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.10.013"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks416"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2014.0113"},{"key":"cit0071","volume":"98","author":"Chen GJ","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1257-6"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-015-0671-z"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001894"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2020.1764531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T04:26:05Z","timestamp":1620447965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2020.1764531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,2]]}},"alternative-id":["10.1080\/14740338.2020.1764531"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2020.1764531","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-12-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}